Bozzini Clarisa, Champin Graciela, Alippi Rosa M, Bozzini Carlos E
Department of Physiology, School of Dentistry, University of Buenos Aires.
Acta Odontol Latinoam. 2015 Apr;28(1):83-8. doi: 10.1590/S1852-48342015000100012.
Long-term glucocorticoid administration to growing rats induces osteopenia and alterations in the biomechanical behavior of the bone. This study was performed to estimate the effects of dexamethasone (DTX), a synthetic steroid with predominant glucocorticoid activity, on the biomechanical properties of the mandible of rats during the growth phase, as assessed by bending test and peripheral quantitative computed tomographic (pQCT) analysis. The data obtained by the two methods will provide more precise information when analyzed together than separately. Female rats aged 23 d (n=7) received 500μg.kg-1 per day of DXT for 4 weeks. At the end of the treatment period, their body weight and body length were 51.3% and 20.6% lower, respectively, than controls. Hemimandible weight and area (an index of mandibular size) were 27.3% and 9.7% lower, respectively. The right hemimandible of each animal was subjected to a mechanical 3-point bending test. Significant weakening of the bone, as shown by a correlative impairment of strength and stiffness, was observed in experimental rats. Bone density and cross-sectional area were measured by pQCT. Cross-sectional, cortical and trabecular areas were reduced by 20% to 30% in the DTX group, as were other cortical parameters, including the bone density, mineral content and cross-sectional moment of inertia. The "bone strength index" (BSI, the product of the pQCT-assessed xCSMI and vCtBMD) was 56% lower in treated rats, which compares well with the 54% and 52% reduction observed in mandibular strength and stiffness determined through the bending test. Data suggest that the corticosteroid exerts a combined, negative action on bone geometry (mass and architecture) and volumetric bone mineral density of cortical bone, which would express independent effects on both cellular (material quality) and tissue (cross-sectional design) levels of biological organization of the skeleton in the species.
对生长中的大鼠长期给予糖皮质激素会导致骨质减少以及骨骼生物力学行为的改变。本研究旨在评估地塞米松(DTX),一种具有主要糖皮质激素活性的合成类固醇,对大鼠生长阶段下颌骨生物力学特性的影响,通过弯曲试验和外周定量计算机断层扫描(pQCT)分析进行评估。两种方法获得的数据一起分析时比单独分析能提供更精确的信息。23日龄的雌性大鼠(n = 7)每天接受500μg.kg-1的DTX,持续4周。在治疗期结束时,它们的体重和体长分别比对照组低51.3%和20.6%。半侧下颌骨重量和面积(下颌骨大小的指标)分别低27.3%和9.7%。对每只动物的右侧半侧下颌骨进行机械三点弯曲试验。在实验大鼠中观察到骨明显变弱,表现为强度和刚度的相关损伤。通过pQCT测量骨密度和横截面积。DTX组的横截面积、皮质骨和小梁骨面积减少了20%至30%,其他皮质参数,包括骨密度、矿物质含量和截面惯性矩也减少了。治疗大鼠的“骨强度指数”(BSI,pQCT评估的xCSMI和vCtBMD的乘积)降低了56%,这与通过弯曲试验测定的下颌骨强度和刚度降低54%和52%相当。数据表明,皮质类固醇对皮质骨的骨几何形状(质量和结构)和体积骨矿物质密度产生综合负面作用,这将在该物种骨骼生物组织的细胞(材料质量)和组织(横截面设计)水平上表现出独立作用。